Pfizer (PFE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TJX (TJX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the ...

ATLANTA — ATLANTA — Acuity Inc. (AYI) on Thursday reported fiscal third-quarter net income of $98.4 million. The Atlanta-based company said it had net income of $3.12 per share. Earnings, adjusted for ...

Acuity, which belongs to the Zacks Technology Services industry, posted revenues of $1.18 billion for the quarter ended May ...

Total S&P 500 earnings for the June quarter are expected to be up +4.9% from the same period last year on +3.9% higher ...

Fluor (FLR) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

Bally's (BALY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

VANCOUVER, British Columbia (AP) — VANCOUVER, British Columbia (AP) — HIVE Digital Technologies Ltd. (HIVE) on Wednesday reported a loss of $52.9 million in its fiscal fourth quarter. On a per-share ...

Walgreens posted quarterly earnings that beat analyst expectations this morning, a potentially positive sign before going ...

OMAHA, Neb. (AP) — OMAHA, Neb. (AP) — Lindsay Corp. (LNN) on Thursday reported net income of $19.5 million in its fiscal third quarter. The Omaha, Nebraska-based company said it had profit of $1.78 ...